Allen AM, Kamath PS, Larson JJ, et al. Cardiovascular Risk in NAFLD- Not an Equal Opportunity: Implications for Women’s Health. AASLD 2017, abstract 55.
FOLFIRINOX versus gemcitabine bij pancreascarcinoom: resultaten na 5 jaar
nov 2022 | Maag-darm-leveroncologie